{"schema_version":"1","generated_at":"2026-11-07T09:30:53.344Z","data_as_of":null,"url":"https://www.findmykol.com/kol/irene-tsung","json_url":"https://www.findmykol.com/kol/irene-tsung/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"irene-tsung","name":"Irene Tsung","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Michigan","institution_url":"https://www.findmykol.com/institution/university-of-michigan","city":"Ann Arbor","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1265882286","orcid":"0000-0002-9105-8659","openalex":"A5009282034"},"summary":"Irene Tsung is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 44 publications with 273 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":273,"h_index":7,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06356155","title":"Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Michigan Rogel Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06356155","trial_url":"https://www.findmykol.com/trial/NCT06356155"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Astellas","program_year":2025,"amount_usd":209439,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265882286"},{"payer":"Merck & Co.","program_year":2025,"amount_usd":88113.81,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265882286"},{"payer":"Ares Trading","program_year":2025,"amount_usd":10320,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265882286"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265882286","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":48.3,"classes_total":3,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":38.1,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":33},{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":8.1,"drugs":[{"name":"Xtandi","share_pct":75},{"name":"Bicalutamide","share_pct":25}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":37.7,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":34.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":39},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":2.9,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":5.7,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":5.7,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":21}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":44.4,"facility_pct":55.6},"source":"medicare"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry","year":2026,"journal":"European Urology Open Science","source_url":"https://doi.org/10.1016/j.euros.2026.02.010","status":"verified"},{"title":"Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database","year":2026,"journal":"Clinical Genitourinary Cancer","source_url":"https://doi.org/10.1016/j.clgc.2026.102501","status":"verified"},{"title":"ICON trial: Phase I/II trial of inulin gel in combination with ipilimumab and nivolumab in advanced renal cell.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.tps572","status":"verified"},{"title":"Outcomes with subsequent therapies post-enfortumab vedotin/pembrolizumab (EVP) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.705","status":"verified"},{"title":"61 Differential Pattern of Disease Recurrence in Resected Renal Cell Carcinoma Patients Treated with Adjuvant Pembrolizumab Versus Observation: A Propensity Score-Weighted Analysis","year":2026,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyag312.062","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 E MEDICAL CENTER DR","city":"Ann Arbor","state":"MI","zip":"481095000","phone":"734-936-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1265882286","source":"identity"},"similar":[{"name":"Max Wicha","slug":"max-wicha","institution":"University of Michigan","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/max-wicha","json_url":"https://www.findmykol.com/kol/max-wicha/profile.json"},{"name":"Eva Feldman","slug":"eva-feldman","institution":"University of Michigan","specialty":"Neurology","url":"https://www.findmykol.com/kol/eva-feldman","json_url":"https://www.findmykol.com/kol/eva-feldman/profile.json"},{"name":"Dinesh Khanna","slug":"dinesh-khanna","institution":"University of Michigan","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/dinesh-khanna","json_url":"https://www.findmykol.com/kol/dinesh-khanna/profile.json"},{"name":"Joshua Ehrlich","slug":"joshua-ehrlich","institution":"University of Michigan","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/joshua-ehrlich","json_url":"https://www.findmykol.com/kol/joshua-ehrlich/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":39}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-09-13","provider_certified":"2023-09-13","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}